Published in TB and Outbreaks Week, August 3rd, 2004
In a recent study from Mexico, the "therapeutic efficacy of three lipid formulations of amphotericin B was compared with that of conventional amphotericin B in treatment of murine coccidioidomycosis."
"All treatments prolonged survival compared with the no-treatment group (p<0.0001)," reported G.M. Gonzalez and coauthors at the Autonomous University of Neuvo Leon.
"Although conventional amphotericin B was more active than lipid formulations on reducing quantitative fungal load on a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.